Elevating vitamin C by oral delivery, intravenous infusion, or intraperitoneal injection could in principle help compensate for the downregulated SVCT2 expression and increase the uptake of vitamin C by breast cancer cells. The gene discussed is SLC23A2; the disease is breast cancer.